Diagnosis and Management of MELAS Syndrome
Author Information
Author(s): Na Ji-Hoon, Lee Young-Mock
Primary Institution: Departments of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
Conclusion
Current management of MELAS syndrome focuses on symptom control and emerging experimental treatments that may improve patient outcomes.
Supporting Evidence
- MELAS syndrome is characterized by a range of systemic manifestations including stroke-like episodes and seizures.
- The m.3243A>G mutation in mitochondrial DNA is the most common cause of MELAS.
- Current treatments focus on symptom management and do not address the underlying genetic causes.
- Emerging therapies like gene therapy and mitochondrial replacement techniques show potential for future treatment.
Takeaway
MELAS is a rare genetic disorder that affects how our cells produce energy, leading to serious health problems. Doctors are working on better ways to help patients manage their symptoms and find new treatments.
Methodology
This review summarizes advancements in the diagnosis and management of MELAS, including genetic testing, imaging techniques, and biochemical assessments.
Limitations
The review highlights the need for further research to fully understand MELAS and improve treatment options.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website